Rectify Pharmaceuticals
Phase 1Discover a novel class of disease-modifying small molecules to treat PSC and other diseases
Founded
2020
Focus
Small Molecules
About
Discover a novel class of disease-modifying small molecules to treat PSC and other diseases
Funding History
2Total raised: $110M
Series A$100MAccess BiotechnologySep 15, 2021
Seed$10MAtlas VentureJan 15, 2020
Company Info
TypePrivate
Founded2020
LocationCambridge, United States
StagePhase 1
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile